A study showed that the CD4+ T cells were significantly increased in tumor, ascites, and peripheral blood of patients with HCC and showed that HBV-specific and HLA class II-restricted CD4+ T cell responses may be related to HBV-related HCC development [21]. Here, CD4 is linked to hepatocellular carcinoma.